Synthesized OVA(323-339)MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cells

BACKGROUND: Antigen-specific immunotherapy (SIT) has been widely practiced in treating allergic diseases such as asthma. However, this therapy may induce a series of allergic adverse events during treatment. Peptide immunotherapy (PIT) was explored to overcome these disadvantages. We confirmed that...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Wen, Zhong, Wenwei, Zhang, Yanjie, Xia, Zhenwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472185/
https://www.ncbi.nlm.nih.gov/pubmed/22769043
http://dx.doi.org/10.1186/1471-2172-13-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472185/
https://www.ncbi.nlm.nih.gov/pubmed/22769043
http://dx.doi.org/10.1186/1471-2172-13-34

Ejemplares similares